Selected research
Market Structure
Global Cetirizine Hydrochloride API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Cetirizine Hydrochloride API market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Cetirizine Hydrochloride API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Cetirizine Hydrochloride API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Cetirizine Hydrochloride API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Cetirizine Hydrochloride API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Cetirizine Hydrochloride API include Merck, Jiangsu Hengrui Medicine, Unichem Laboratories Ltd, Solara Active Pharma Sciences Ltd, LGM Pharma, Ipca Laboratories Ltd, Granules India Ltd and Avanscure Lifesciences, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Cetirizine Hydrochloride API market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Cetirizine Hydrochloride API and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Cetirizine Hydrochloride API sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Cetirizine Hydrochloride API market size, projected growth trends, production technologies, key applications, and end-use industries.
Cetirizine Hydrochloride API Segment by Company
Merck
Jiangsu Hengrui Medicine
Unichem Laboratories Ltd
Solara Active Pharma Sciences Ltd
LGM Pharma
Ipca Laboratories Ltd
Granules India Ltd
Avanscure Lifesciences
Cetirizine Hydrochloride API Segment by Type
Purity≥98%
Purity<98%
Cetirizine Hydrochloride API Segment by Application
Allergic Rhinitis
Allergic Conjunctivitis
Chronic Urticaria
Others
Cetirizine Hydrochloride API Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cetirizine Hydrochloride API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cetirizine Hydrochloride API and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cetirizine Hydrochloride API.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Cetirizine Hydrochloride API market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cetirizine Hydrochloride API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cetirizine Hydrochloride API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Cetirizine Hydrochloride API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Purity≥98%
- Purity<98%
Applications
- Allergic Rhinitis
- Allergic Conjunctivitis
- Chronic Urticaria
- Others
Companies covered
- Merck
- Jiangsu Hengrui Medicine
- Unichem Laboratories Ltd
- Solara Active Pharma Sciences Ltd
- LGM Pharma
- Ipca Laboratories Ltd
- Granules India Ltd
- Avanscure Lifesciences
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Cetirizine Hydrochloride API Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Cetirizine Hydrochloride API Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Cetirizine Hydrochloride API Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Cetirizine Hydrochloride API Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Cetirizine Hydrochloride API Market Dynamics
- 2.1 Cetirizine Hydrochloride API Industry Trends
- 2.2 Cetirizine Hydrochloride API Industry Drivers
- 2.3 Cetirizine Hydrochloride API Industry Opportunities and Challenges
- 2.4 Cetirizine Hydrochloride API Industry Restraints
3 Cetirizine Hydrochloride API Market by Manufacturers
- 3.1 Global Cetirizine Hydrochloride API Revenue by Manufacturers (2021-2026)
- 3.2 Global Cetirizine Hydrochloride API Sales by Manufacturers (2021-2026)
- 3.3 Global Cetirizine Hydrochloride API Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Cetirizine Hydrochloride API Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Cetirizine Hydrochloride API Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Cetirizine Hydrochloride API Manufacturers, Product Type & Application
- 3.7 Global Cetirizine Hydrochloride API Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Cetirizine Hydrochloride API Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Cetirizine Hydrochloride API Players Market Share by Revenue in 2025
- 3.8.3 2025 Cetirizine Hydrochloride API Tier 1, Tier 2, and Tier 3
4 Cetirizine Hydrochloride API Market by Type
- 4.1 Cetirizine Hydrochloride API Type Introduction
- 4.1.1 Purity≥98%
- 4.1.2 Purity<98%
- 4.2 Global Cetirizine Hydrochloride API Sales by Type
- 4.2.1 Global Cetirizine Hydrochloride API Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Cetirizine Hydrochloride API Sales by Type (2021-2032)
- 4.2.3 Global Cetirizine Hydrochloride API Sales Market Share by Type (2021-2032)
- 4.3 Global Cetirizine Hydrochloride API Revenue by Type
- 4.3.1 Global Cetirizine Hydrochloride API Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Cetirizine Hydrochloride API Revenue by Type (2021-2032)
- 4.3.3 Global Cetirizine Hydrochloride API Revenue Market Share by Type (2021-2032)
5 Cetirizine Hydrochloride API Market by Application
- 5.1 Cetirizine Hydrochloride API Application Introduction
- 5.1.1 Allergic Rhinitis
- 5.1.2 Allergic Conjunctivitis
- 5.1.3 Chronic Urticaria
- 5.1.4 Others
- 5.2 Global Cetirizine Hydrochloride API Sales by Application
- 5.2.1 Global Cetirizine Hydrochloride API Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Cetirizine Hydrochloride API Sales by Application (2021-2032)
- 5.2.3 Global Cetirizine Hydrochloride API Sales Market Share by Application (2021-2032)
- 5.3 Global Cetirizine Hydrochloride API Revenue by Application
- 5.3.1 Global Cetirizine Hydrochloride API Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Cetirizine Hydrochloride API Revenue by Application (2021-2032)
- 5.3.3 Global Cetirizine Hydrochloride API Revenue Market Share by Application (2021-2032)
6 Global Cetirizine Hydrochloride API Sales by Region
- 6.1 Global Cetirizine Hydrochloride API Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Cetirizine Hydrochloride API Sales by Region (2021-2032)
- 6.2.1 Global Cetirizine Hydrochloride API Sales by Region (2021-2026)
- 6.2.2 Global Cetirizine Hydrochloride API Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Cetirizine Hydrochloride API Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Cetirizine Hydrochloride API Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Cetirizine Hydrochloride API Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Cetirizine Hydrochloride API Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Cetirizine Hydrochloride API Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Cetirizine Hydrochloride API Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Cetirizine Hydrochloride API Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Cetirizine Hydrochloride API Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Cetirizine Hydrochloride API Revenue by Region
- 7.1 Global Cetirizine Hydrochloride API Revenue by Region
- 7.1.1 Global Cetirizine Hydrochloride API Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Cetirizine Hydrochloride API Revenue by Region (2021-2026)
- 7.1.3 Global Cetirizine Hydrochloride API Revenue by Region (2027-2032)
- 7.1.4 Global Cetirizine Hydrochloride API Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Cetirizine Hydrochloride API Revenue (2021-2032)
- 7.2.2 North America Cetirizine Hydrochloride API Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Cetirizine Hydrochloride API Revenue (2021-2032)
- 7.3.2 Europe Cetirizine Hydrochloride API Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Cetirizine Hydrochloride API Revenue (2021-2032)
- 7.4.2 Asia-Pacific Cetirizine Hydrochloride API Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Cetirizine Hydrochloride API Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Cetirizine Hydrochloride API Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Merck
- 8.1.1 Merck Company Information
- 8.1.2 Merck Business Overview
- 8.1.3 Merck Cetirizine Hydrochloride API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Merck Cetirizine Hydrochloride API Product Portfolio
- 8.1.5 Merck Recent Developments
- 8.2 Jiangsu Hengrui Medicine
- 8.2.1 Jiangsu Hengrui Medicine Company Information
- 8.2.2 Jiangsu Hengrui Medicine Business Overview
- 8.2.3 Jiangsu Hengrui Medicine Cetirizine Hydrochloride API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Jiangsu Hengrui Medicine Cetirizine Hydrochloride API Product Portfolio
- 8.2.5 Jiangsu Hengrui Medicine Recent Developments
- 8.3 Unichem Laboratories Ltd
- 8.3.1 Unichem Laboratories Ltd Company Information
- 8.3.2 Unichem Laboratories Ltd Business Overview
- 8.3.3 Unichem Laboratories Ltd Cetirizine Hydrochloride API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Unichem Laboratories Ltd Cetirizine Hydrochloride API Product Portfolio
- 8.3.5 Unichem Laboratories Ltd Recent Developments
- 8.4 Solara Active Pharma Sciences Ltd
- 8.4.1 Solara Active Pharma Sciences Ltd Company Information
- 8.4.2 Solara Active Pharma Sciences Ltd Business Overview
- 8.4.3 Solara Active Pharma Sciences Ltd Cetirizine Hydrochloride API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Solara Active Pharma Sciences Ltd Cetirizine Hydrochloride API Product Portfolio
- 8.4.5 Solara Active Pharma Sciences Ltd Recent Developments
- 8.5 LGM Pharma
- 8.5.1 LGM Pharma Company Information
- 8.5.2 LGM Pharma Business Overview
- 8.5.3 LGM Pharma Cetirizine Hydrochloride API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 LGM Pharma Cetirizine Hydrochloride API Product Portfolio
- 8.5.5 LGM Pharma Recent Developments
- 8.6 Ipca Laboratories Ltd
- 8.6.1 Ipca Laboratories Ltd Company Information
- 8.6.2 Ipca Laboratories Ltd Business Overview
- 8.6.3 Ipca Laboratories Ltd Cetirizine Hydrochloride API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Ipca Laboratories Ltd Cetirizine Hydrochloride API Product Portfolio
- 8.6.5 Ipca Laboratories Ltd Recent Developments
- 8.7 Granules India Ltd
- 8.7.1 Granules India Ltd Company Information
- 8.7.2 Granules India Ltd Business Overview
- 8.7.3 Granules India Ltd Cetirizine Hydrochloride API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Granules India Ltd Cetirizine Hydrochloride API Product Portfolio
- 8.7.5 Granules India Ltd Recent Developments
- 8.8 Avanscure Lifesciences
- 8.8.1 Avanscure Lifesciences Company Information
- 8.8.2 Avanscure Lifesciences Business Overview
- 8.8.3 Avanscure Lifesciences Cetirizine Hydrochloride API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Avanscure Lifesciences Cetirizine Hydrochloride API Product Portfolio
- 8.8.5 Avanscure Lifesciences Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Cetirizine Hydrochloride API Value Chain Analysis
- 9.1.1 Cetirizine Hydrochloride API Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Cetirizine Hydrochloride API Production Mode & Process
- 9.2 Cetirizine Hydrochloride API Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Cetirizine Hydrochloride API Distributors
- 9.2.3 Cetirizine Hydrochloride API Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst